Novelix Pharmaceuticals Limited (BOM:536565)
56.54
+2.39 (4.41%)
At close: Apr 21, 2026
Novelix Pharmaceuticals Market Cap
Novelix Pharmaceuticals has a market cap or net worth of 1.13 billion as of April 22, 2026. Its market cap has increased by 671.35% in one year.
Market Cap
1.13B
Enterprise Value
1.11B
Revenue
1.28B
Ranking
n/a
PE Ratio
47.18
Stock Price
56.54
Market Cap Chart
Since March 25, 2009, Novelix Pharmaceuticals's market cap has increased from 73.58M to 1.13B, an increase of 1,431.94%. That is a compound annual growth rate of 17.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 1.10B | 1.89% |
| Dec 31, 2025 | 1.08B | 348.62% |
| Dec 30, 2024 | 240.29M | 163.70% |
| Dec 29, 2023 | 91.13M | 8.70% |
| Dec 30, 2022 | 83.84M | 54.48% |
| Dec 31, 2021 | 54.27M | 8.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Khemani Distributors & Marketing | 3.04B |
| Aptus Pharma | 2.60B |
| Chemkart India | 1.71B |
| Rama Vision | 1.67B |
| VijayPD Ceutical | 1.38B |
| Achyut Healthcare | 1.33B |
| Constronics Infra | 684.21M |
| Checkpoint Trends | 335.53M |